维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="Brit G"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Atherosclerotic lesions in lymphoma survivors treated with radiotherapy显示文摘	Torgeir Wethal B?rd Nedregaard Rune Andersen Alexander Foss? May Brit Lund Anne Günther Stein Kval?y Sophie D. Foss? John Kjekshus	2013	Radiotherapy and Oncology2013，，：	1
	2	Photolysis of uranyl oxalate system 3:photochemical behavior,kinetics- and mechanism in aqueous-solution显示文摘	Brits A G Vaneldik R Vandenberg J A	1977	J Inorg Nucl Chem1977，39，7：	1
	3	Photolysis of uranyl formic acid formate system in acidic aqueous solution显示文摘	Brits A G Vaneldik R Vandenberg J A	1978	Inorg Chim Acta1978，30，1：	1
	4	Genotoxicity of PM10 and extracted organics collected in an industrial, urban and rural area in Flanders, Belgium 显示文摘	BRITS E SCHOETERS G VERSCHAEVE L	2004	Environ Res2004，96，2：	1
	5	Refined genetic algorithm-economic dispatch example显示文摘	Sheble G B Britting K	1995	IEEE Trans on Power Systems1995，10，1：	1
	6	Simultaneous versus sequential public good provision and the role of refunds:An experimental study显示文摘	Jennifer C Timothy G Brit G	2009	Journal of Public Economics2009，93，12：	1
	7	Refined genetic algorithm economic dispatch example 显示文摘	Sheble G B Britting K	1995	IEEE Trans on Power Systems1995，10，1：	1
	8	Entertoxion production and serogroups of campylobacter jejuni and campylobacter ecoli from healthy lying hens 显示文摘	Brit G Bertil L Evasjogen K	1989	J Clin Miembiol1989，6，：	1
	9	Genotoxicity of PM10 and extracted organics collected in an industrial, urban and rural area in Flanders, Belgium显示文摘	Brits E Schoetcrs G Verschacvc L	2004	Envi Rcs2004，96，2：	1
	10	Refined genetic algorithm-economic dispatchexample显示文摘	Sheble G B Kristin Britting	1995	IEEE Transactions on Power Systems1995，10，1：	1
	11	No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors显示文摘Background:IgG-class autoantibodies to N-Methyl-D-Aspartate(NMDA)-type glutamate receptors define a novel entity of autoimmune encephalitis.Studies examining the prevalence of NMDA IgA/IgM antibodies in patients with Parkinson disease with/without dementia produced conflicting results.We measured NMDA antibodies in a large,well phenotyped sample of Parkinson patients without and with cognitive impairment(n=296)and controls(n=295)free of neuropsychiatric disease.Detailed phenotyping and large numbers allowed statistically meaningful correlation of antibody status with diagnostic subgroups as well as quantitative indicators of disease severity and cognitive impairment.Methods:NMDA antibodies were analysed in the serum of patients and controls using well established validated assays.We used anti-NMDA antibody positivity as the main independent variable and correlated it with disease status and phenotypic characteristics.Results:The frequency of NMDA IgA/IgM antibodies was lower in Parkinson patients(13%)than in controls(22%)and higher than in previous studies in both groups.NMDA IgA/IgM antibodies were neither significantly associated with diagnostic subclasses of Parkinson disease according to cognitive impairment,nor with quantitative indicators of disease severity and cognitive impairment.A positive NMDA antibody status was positively correlated with age in controls but not in Parkinson patients.Conclusion:It is unlikely albeit not impossible that NMDA antibodies play a significant role in the pathogenesis or progression of Parkinson disease e.g.to Parkinson disease with dementia,while NMDA IgG antibodies define a separate disease of its own.	Franziska Hopfner Stefanie HMüller Dagmar Steppat Joanna Miller Nele Schmidt Klaus-Peter Wandinger Frank Leypoldt Daniela Berg Andre Franke Wolfgang Lieb Lukas Tittmann Monika Balzer-Geldsetzer Simon Baudrexel Richard Dodel Ruediger Hilker-Roggendorf Elke Kalbe Jan Kassubek Thomas Klockgether Inga Liepelt-Scarfone Brit Mollenhauer Petra Neuser Kathrin Reetz Oliver Riedel Claudia Schulte Jörg BSchulz Annika Spottke Alexander Storch Claudia Trenkwalder Hans-Ulrich Wittchen Karsten Witt Ullrich Wüllner Günther Deuschl Gregor Kuhlenbäumer	2019	Translational Neurodegeneration2019，8，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费